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 PKD1 alleles exist and may account for the 
considerable variability in disease seen in 
some families. Further analysis of and addi-
tional large-scale mutation screens in 
ADPKD supported by detailed phenotypic 
analysis and family studies are now required 
to determine whether the total burden of all 
sequence variants and missense changes, 
either  in cis or  trans , is correlated with 
disease severity. It is an intriguing thought 
that total sequence variation in  PKD1 itself 
may be a major determinant of disease 
severity and variability. 
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 The goddess of the waters 
 Harry  van Goor 1 and  Henri G.D.  Leuvenink 2 
 The renal lymphatic system is cardinal in circulatory physiology and 
immunology. Sakamoto  et al. report that lymphatic angiogenesis is 
increased in tubulointerstitial lesions in human chronic renal disease 
and correlates with tissue damage. Moreover, lymphatic growth was 
associated with vascular endothelial growth factor-C (VEGF-C) expression 
in mononuclear and tubular epithelial cells. Diabetic nephropathy had 
the highest level of VEGF-C and the most extensive lymphangiogenesis. 
The data suggest that lymphangiogenesis is a common feature in the 
progression of tubulointerstitial fibrosis. 
 Kidney International (2009)  75, 767 – 769.  doi: 10.1038/ki.2009.45 
 Why not start with a reference to Hippoc-
rates, who is thought to have  rst discov-
ered the existence of lymph?  Lympha 
originates from the Greek word  nymphe , 
a goddess of the waters. So, it is crystal 
clear that lymph is a colorless fluid —
 except for the lymph found in the lacteal 
vessels of the mesentericum, which turns 
white a4 er a meal because of the absorp-
tion of dietary fats as  rst described by 
Asellio during the Renaissance. * e tradi-
tional functions of the lymphatic system 
are ascribed to circulatory physiology and 
immunology. Fluid leaking through the 
semipermeable capillary bed into the 
interstitium, a4 er picking up antigens and 
immunologically active cells, is collected 
in lymph capillaries, drained to regional 
lymph nodes, and exposed to the lymphoid 
system. A4 er  ltration, the lymph 9 uid 
returns to the blood and continues its life-
long task: the draining of organs under 
physiological conditions. * e lymph drain-
age system becomes especially challenged 
during disease conditions such as wound 
healing, inflammation, and infection, 
when excessive 9 uid, lymphocytes, and 
dendritic cells travel through the lymphatic 
vessels to the lymph nodes. * is is not an 
indolent process, but a masterminded sys-
tem in which adhesion molecules, 
cytokines, and chemokines are crucially 
involved. During disease states, the 
number and maturation state of dendritic 
cells increase dramatically. Knowledge of 
how leukocytes migrate over the lymphatic 
wall is sparse, although intercellular adhe-
sion molecule-1 (ICAM-1) and vascular 
cell adhesion molecule-1 (VCAM-1) are 
known to be involved, as ICAM-1-de -
cient mice have a defect in lymph node 
recruitment of dendritic cells. * e role of 
cellular traI  cking through the lymphatic 
system also painfully reveals unappreci-
ated side e: ects such as are seen in the 
dissemination of metastatic cancer cells. 
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 In the experimental setting, the func-
tional role of lymphatics has become more 
evident. Acute ureteral obstruction causes 
dilation and re9 ux into intrarenal lym-
phatics. Interestingly, in chronic obstruc-
tion, Tamm-Horsfall proteins leak from 
tubules into the lymphatics and can be 
found in lymph nodes in the hilum of the 
kidney. In short-term hilar lymph duct liga-
tion, Wilcox  et al. noted that lymphatic 
drainage is required to maintain a low renal 
cortical hydraulic pressure and that ligation 
decreases sodium and 9 uid reabsorption. 1 
* e relation of lymphatics to renal  brosis 
has been studied in several models. In re9 ux 
nephropathy,  brosis follows the distribu-
tion of lymphatics. In remnant kidneys, 
proliferation of lymphatic vessels was 
observed in the  brotic tubulointerstitial 
areas. 2 Disturbance of the lymph circulation 
by lymphatic duct ligation alone or in com-
bination with nephrectomy causes pro-
teinuria and renal  brosis. 3 
 Several markers of the endothelial cells 
lining the lymphatic vessels are now avail-
able, including LYVE-1 (hyaluronate 
receptor), Prox-1 (lymphatic transcription 
factor), podoplanin (a type I integral mem-
brane glycoprotein), factors of the vascular 
endothelial growth factor family (VEGF), 
and the sialoglycoprotein D2-40 (a lym-
phatic endothelium-speci c protein). * e 
localization of the normal renal lymphatic 
vessels has been described in animals and 
humans and reveals the abundant presence 
around intrarenal arteries and veins, with 
a more scarce localization around glomer-
uli and between tubules. Medullary 
lymphatics are extremely rare. 
 Lymphatics have been of special interest 
in the  eld of renal transplantation, in 
which the lymphatic system is not restored 
during implantation, in contrast to the 
vascular system. One of the key physio-
logical questions was whether disruption 
of lymphatic drainage would in9 uence 
functioning of the gra4 . Early studies pro-
vided evidence that the disruption is not 
harmful for the kidney and that the lym-
phatic system is restored over time. 4 Even 
more crucial is the role of renal lymphat-
ics in the immunological response a4 er 
renal transplantation. In allogra4  rejec-
tion, cellular in ltrates are key elements, 
and lymphatics provide an exit route for 
lymphocytes and macrophages. Recently, 
the presence of newly formed lymphatic 
vessels in human renal transplant biopsies 
near the nodular cell infiltrates was 
reported. 5 * e presence of these lymphatic 
structures is thought to be involved not 
only in removal of the rejection in ltrate 
but also in the continuing alloreactive 
immune response leading to chronic 
rejection. 6 Newly formed lymphatic ves-
sels presumably also organize the perivas-
cular lymphocytes into immunologically 
active follicular structures, that are 
involved in the survival of the transplant. 
Interestingly, lymphangiogenesis occurs 
early, within 72  h a4 er transplantation. 
Findings of Stuht  et al. 7 indicate that the 
number of lymphatic vessels does not 
increase in time, nor is it correlated with 
rejection in the  rst year, but that it is cor-
related with worse functional gra4  out-
come. * is suggests that early damage to 
the gra4  during the transplantation, or 
maybe even in the donor situation, 
increases the susceptibility of the gra4  to 
rejection. * is is also illustrated by the 
report of Franksson  et al. in which lym-
phocyte depletion by drainage of lymph 
via thoracic duct  stula was found to be a 
beneficial supplementary treatment 
modality in regard to one-year gra4  sur-
vival when combined with anti-thymocyte 
serum in cadaveric gra4  recipients but not 
in recipients receiving a living-donor 
organ. 8 * e renewed interest and novel 
 ndings in the  eld of cell traI  c and lym-
phatic endothelium indicate that the lym-
phatic endothelium is a potential target 
for immunosuppressive therapy. 9 An 
intact lymphatic system might be pivotal, 
not only for the immune surveillance of 
the alloresponse, but also for the clearance 
of all kinds of pathogens attacking the 
transplant — for example, viruses such as 
herpes, as well as polyoma viruses. 
 * e macrophage is central in the patho-
genesis of renal  brosis and repair 10 and 
also contributes to the formation of lym-
phatic vessels through production of 
VEGF-C ( Figure 1 ). * e lymphatic ves-
sels and interstitium of remnant kidneys 
contain mononuclear cells that express 
VEGF-C mRNA. Maruyama  et al. studied 
lymphangiogenesis in diabetes and found 
that renal macrophages contribute to the 
formation of lymphatics. 11 Surprisingly, 
glucose  per se or interleukin-1  decreased 
the production of VEGF-C in macrophages, 
whereas the combination of the two caused 
a signi cant increase in VEGF-C produc-
tion, revealing the lymphangiogenic poten-
tial of these cells in in9 ammatory diabetic 
conditions ( Figure 1 ). Moreover, application 
of interleukin-1  to wounds in  db / db mice 
induced lymphatic vessel formation and 
accelerated wound healing. A second 
phenomenon central to the pathogenesis of 
diabetic nephropathy is the formation and 
accumulation of advanced glycation end 
products (AGEs). 12 AGEs have also been 
shown to be able to activate macrophages 
and induce induction of VEGF in these cells. 
In this way AGEs may also contribute to the 
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 Figure 1  |  Simplified scheme of the development of lymphangiogenesis in interstitial fibrosis 
associated with diabetic nephropathy. Clusters of macrophages are present in the fibrotic interstitium. 
These macrophages are activated in an autocrine or paracrine fashion through the production of cytokines 
such as interleukin-1  . Glucose is present in the interstitial fibrotic areas, as are advanced glycation end 
products (AGEs). All these factors contribute to the production of vascular endothelial growth factor-C 
(VEGF-C) by macrophages and thereby to the formation of lymphatics. ECM, extracellular matrix. 
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formation of lymphatics. Hypoxia induced 
by vessel damage and  brosis is another cru-
cial factor involved in the pathogenesis of 
diabetic renal disease damage. It is known 
from the oncology  eld that the invasion and 
migration of microvascular endothelial 
cells is increased during hypoxia. 13 
 Sakamoto  et al. 14 (this issue) investigated 
the expression of D2-40 – positive lymphatic 
vessels, with special interest in VEGF-C, a 
crucial mediator of lymphan-giogenesis in 
chronic renal disease. * ey meticulously 
mapped the presence of lymphatic vessels in 
a wide range of renal diseases using D2-40 
and VEGF-C antibodies. * ey con rmed 
the absence of corticomedullary lymphatics 
in control kidneys but found lymphangio-
genesis in tubulointerstitial fibrosis and 
in9 ammatory interstitial areas in various 
renal diseases. * ese vessels were o4 en  lled 
with mononuclear cells. Interestingly, lym-
phangiogenesis and VEGF-C expression 
were elevated in diabetic nephropathy as 
compared with other renal diseases. 
 * e study is a solid base for continuing 
research, as several questions remain and 
have to be resolved. For instance, do glucose 
and AGEs have any e: ect on the produc-
tion of VEGF-C by resident glomerular cells 
and the subsequent growth of lymphatic 
vessels? * is question can easily be resolved 
in an  in vitro setup. What are the other 
signals involved in lymphangiogenesis? Do 
components of the extracellular matrix 
 per se have any e: ect on lymphangiogenesis? 
And what about ischemia, a central event in 
chronic renal disease and renal transplanta-
tion; does it provoke VEGF-C expression and 
lymphangiogenesis? What is the role of cy -
closporine in the formation of lymphatics? 
 Despite all these questions, this 
elegant, elaborate study of Sakamoto 
 et al. 14 de nitely paves the way for further 
research in the field of lymphatics in 
chronic renal disease. Novel therapeutic 
interventions aiming at the modulation of 
growth and proliferation of lymphatic cells 
may lead to better treatment modalities and 
understanding of chronic renal disease. 
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 Regulation of renal arteriolar tone 
by adenosine: novel role 
for type 2 receptors 
 Tracy D.  Bell 1 and  William J.  Welch 1 
 Tubuloglomerular feedback regulation of glomerular filtration rate 
(GFR) is mediated by adenosine, which acts on type 1 receptors in the 
afferent arteriole to increase resistance. However, new findings in 
isolated mouse tissue suggest that adenosine also dilates the efferent 
arteriole, which would reinforce the ability of adenosine to reduce GFR. 
This new information extends the concept that adenosine acts as a 
paracrine agent on both afferent and efferent arterioles. 
 Kidney International (2009)  75, 769 – 771.  doi: 10.1038/ki.2009.18 
see original article on page 793
 Regulation of glomerular  ltration is a 
critical element of the homeostatic func-
tion of the kidney to maintain stable 9 uid 
and electrolyte balance. Much of this regu-
lation is dependent on the control of the 
renal arterioles surrounding the glomeru-
lar capillary. * e study by Al-Mashhadi 
et al. 1 (this issue) provides new informa-
tion and clarification of a potentially 
important mechanism that targets e: erent 
arteriolar tone. The authors show that 
adenosine acting on type 2 receptors 
dilates the e: erent arteriole. * is provides 
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